|
Based on the information available, no conclusions can be made.As reported, patient experienced post-op complication of erythema/redness.Medical affairs has assessed the aes as being likely related to the device and serious.Review of the device history records confirms the device was manufactured to specification.Remains implanted.
|
|
Per clinical trial (b)(4): on (b)(6) 2018, patient underwent bilateral mastopexy/reduction; medial pedicle, using a wise pattern - superiomedial pedicle.2 pieces of galaflex were used.Concomitant procedures included: fat grafting to breasts/ liposuction to flanks, upper back, buffalo hump, abdomen, axilla.On (b)(6) 2018, erythema/redness; right vertical incision, was reported.Patient treated with medication (cipro 500mg).Betadine and non-stick pad.Resolved without sequelae on (b)(6) 2018.Review of medical affairs identified that the erythema/redness is likely related to the device and serious.
|